Drug And Gene Delivery Devices Market To Reach $1.22 Billion By 2030

Drug And Gene Delivery Devices Market Growth & Trends

The global drug and gene delivery devices market size is expected to reach USD 1.22 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.

Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.

 Request a free sample copy or view report summary: Drug And Gene Delivery Systems Market Report

Drug And Gene Delivery Devices Market Report Highlights

• In 2023, the oral segment dominated the market and accounted for the largest revenue share of 52.7%, owing to its convenience and ease of administration.

• The injectable segment is expected to witness the fastest CAGR of 11.0% during the forecast period, fueled by increasing prevalence of life-threatening diseases and advancement in injectable drug delivery devices.

• In 2023, North America dominated the drug and gene delivery devices market with a revenue share of 54.0%, owing to the rising number of people suffering from chronic diseases.

• The drug and gene delivery devices market in Asia Pacific is projected to witness growth during the forecast period. The growth can be attributed to the increasing prevalence of chronic diseases such as heart disease, diabetes and cancer owing to the changing lifestyle, increase in consumption of alcohols and cigarettes.

Drug And Gene Delivery Devices Market Segmentation

Grand View Research has segmented the global drug and gene delivery devices market on the basis of on route of administration, vector and region:

Drug And Gene Delivery Devices Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral

• Inhalation

• Transdermal

• Injectable

• Ocular

• Nasal

• Topical

Drug And Gene Delivery Devices Vector Outlook (Revenue, USD Million, 2018 - 2030)

• Viral

• Non-viral

Drug And Gene Delivery Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Drug And Gene Delivery Devices Market

• Uniqure N.V., 

• SiBiono GeneTech Co.

• Epeius Biotechnologies Corporation

• Shanghai Sunway Biotech Co., Ltd

• Pfizer, Inc.

• F. Hoffmann-La Roche Ltd.

• Johnson and Johnson

• Novartis AG

• Bayer AG

• Becton, Dickinson and Company